Gilad Shalit deal may be imminent
Haaretz reports that Israeli negotiators are staying in Cario for an extra day to secure the release of captured IDF soldier Gilad Shalit, who has been held by Hamas since 2006, and are close to an agreement. The head of Hamas’s military wing is reportedly heading negotiations on their side. Citing the pan-Arab paper Al ...
Haaretz reports that Israeli negotiators are staying in Cario for an extra day to secure the release of captured IDF soldier Gilad Shalit, who has been held by Hamas since 2006, and are close to an agreement. The head of Hamas's military wing is reportedly heading negotiations on their side. Citing the pan-Arab paper Al Hayat, the article describes the possible conditions for Shalit's release:
Haaretz reports that Israeli negotiators are staying in Cario for an extra day to secure the release of captured IDF soldier Gilad Shalit, who has been held by Hamas since 2006, and are close to an agreement. The head of Hamas’s military wing is reportedly heading negotiations on their side. Citing the pan-Arab paper Al Hayat, the article describes the possible conditions for Shalit’s release:
The newspaper also reported that Israel is willing to release 300 Palestinian prisoners out of 450 on a list presented by Hamas, but maintains its opposition to the remaining 150, some of whom have been convicted of involvement in terrorist attacks.
Joshua Keating was an associate editor at Foreign Policy. Twitter: @joshuakeating
More from Foreign Policy

Saudi-Iranian Détente Is a Wake-Up Call for America
The peace plan is a big deal—and it’s no accident that China brokered it.

The U.S.-Israel Relationship No Longer Makes Sense
If Israel and its supporters want the country to continue receiving U.S. largesse, they will need to come up with a new narrative.

Putin Is Trapped in the Sunk-Cost Fallacy of War
Moscow is grasping for meaning in a meaningless invasion.

How China’s Saudi-Iran Deal Can Serve U.S. Interests
And why there’s less to Beijing’s diplomatic breakthrough than meets the eye.